Gene expression profiles induced by cancer chemopreventive isothiocyanate sulforaphane in the liver of C57BL/6J mice and C57BL/6J/Nrf2 (-/-) mice

Cancer Letters

Volumn 243, Issue 2, 2006, Pages 170-192

  Hu, Rong ^a   Xu, Changjiang ^a   Shen, Guoxiang ^a   Jain, Mohit R ^a   Khor, Tin Oo ^a   Gopalkrishnan, Avantika ^a   Lin, Wen ^a   Reddy, Bandaru ^a   Chan, Jefferson Y ^b   Kong, Ah Ng Tony ^a,b  

^a RUTGERS UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antioxidant response element; Gene expression profile; Knock out mice; Microarray; Nrf2; Phase II detoxifying genes; SFN

Indexed keywords

DNA; HEAT SHOCK PROTEIN; ISOTHIOCYANATE SULFORAPHANE; ISOTHIOCYANIC ACID DERIVATIVE; PROTEASOME; REACTIVE OXYGEN METABOLITE; UBIQUITIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CELL SURVIVAL; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DETOXIFICATION; DNA DAMAGE; DNA DETERMINATION; DNA MICROARRAY; GENE EXPRESSION; GENE IDENTIFICATION; GENETIC TRANSCRIPTION; LIPID METABOLISM; LIVER CARCINOMA; MEMBRANE TRANSPORT; MOLECULAR RECOGNITION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; UNINDEXED SEQUENCE; WILD TYPE;

ANIMALS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; LIVER; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NF-E2-RELATED FACTOR 2; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; THIOCYANATES; TRANSCRIPTIONAL ACTIVATION;

EID: 33746889956     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2005.11.050     Document Type: Article

References (78)

1. Verhoeven D.T., Goldbohm R.A., van Poppel G., Verhagen H., and van den Brandt P.A. Epidemiological studies on brassica vegetables and cancer risk. Cancer Epidemiol. Biomarkers Prev. 5 (1996) 733-748
2. Rijken P.J., Timmer W.G., van de Kooij A.J., van Benschop I.M., Wiseman S.A., Meijers M., et al. Effect of vegetable and carotenoid consumption on aberrant crypt multiplicity, a surrogate end-point marker for colorectal cancer in azoxymethane-induced rats. Carcinogenesis 20 (1999) 2267-2272
3. Michaud D.S., Spiegelman D., Clinton S.K., Rimm E.B., Willett W.C., and Giovannucci E.L. Fruit and vegetable intake and incidence of bladder cancer in a male prospective cohort. J. Natl Cancer Inst. 91 (1999) 605-613
4. Wang L.I., Giovannucci E.L., Hunter D., Neuberg D., Su L., and Christiani D.C. Dietary intake of cruciferous vegetables, glutathione S-transferase (GST) polymorphisms and lung cancer risk in a Caucasian population. Cancer Causes Control 15 (2004) 977-985
5. Bueno de Mesquita H.B., Maisonneuve P., Runia S., and Moerman C.J. Intake of foods and nutrients and cancer of the exocrine pancreas: a population-based case-control study in The Netherlands. Int. J. Cancer 48 (1991) 540-549
6. Michaud D.S., Pietinen P., Taylor P.R., Virtanen M., Virtamo J., and Albanes D. Intakes of fruits and vegetables, carotenoids and vitamins A, E, C in relation to the risk of bladder cancer in the ATBC cohort study. Br. J. Cancer 87 (2002) 960-965
7. Joseph M.A., Moysich K.B., Freudenheim J.L., Shields P.G., Bowman E.D., Zhang Y., et al. Cruciferous vegetables, genetic polymorphisms in glutathione S-transferases M1 and T1, and prostate cancer risk. Nutr. Cancer 50 (2004) 206-213
8. Pan S.Y., Ugnat A.M., Mao Y., Wen S.W., and Johnson K.C. A case-control study of diet and the risk of ovarian cancer. Cancer Epidemiol. Biomarkers Prev. 13 (2004) 1521-1527
9. Kune G.A., Bannerman S., Field B., Watson L.F., Cleland H., Merenstein D., et al. Diet, alcohol, smoking, serum beta-carotene, and vitamin A in male nonmelanocytic skin cancer patients and controls. Nutr. Cancer 18 (1992) 237-244
10. Hara M., Hanaoka T., Kobayashi M., Otani T., Adachi H.Y., Montani A., et al. Cruciferous vegetables, mushrooms, and gastrointestinal cancer risks in a multicenter, hospital-based case-control study in Japan. Nutr. Cancer 46 (2003) 138-147
11. Seow A., Yuan J.M., Sun C.L., Van Den Berg D., Lee H.P., and Yu M.C. Dietary isothiocyanates, glutathione S-transferase polymorphisms and colorectal cancer risk in the Singapore Chinese Health Study. Carcinogenesis 23 (2002) 2055-2061
12. Talalay P. Chemoprotection against cancer by induction of phase 2 enzymes. Biofactors 12 (2000) 5-11
13. Zhu M., and Fahl W.E. Functional characterization of transcription regulators that interact with the electrophile response element. Biochem. Biophys. Res. Commun. 289 (2001) 212-219
14. Chen C., and Kong A.N. Dietary chemopreventive compounds and ARE/EpRE signaling. Free Radic. Biol. Med. 36 (2004) 1505-1516
15. Enomoto A., Itoh K., Nagayoshi E., Haruta J., Kimura T., O'Connor T., et al. High sensitivity of Nrf2 knockout mice to acetaminophen hepatotoxicity associated with decreased expression of ARE-regulated drug metabolizing enzymes and antioxidant genes. Toxicol. Sci. 59 (2001) 169-177
16. Ramos-Gomez M., Kwak M.K., Dolan P.M., Itoh K., Yamamoto M., Talalay P., et al. Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in nrf2 transcription factor-deficient mice. Proc. Natl Acad. Sci. USA 98 (2001) 3410-3415
17. Yu R., Mandlekar S., Harvey K.J., Ucker D.S., and Kong A.-N.T. Chemopreventive isothiocyanates induce apoptosis and caspase-3-like protease activity. Cancer Res. 58 (1998) 402-408
18. Hu R., Kim B.R., Chen C., Hebbar V., and Kong A.N. The roles of JNK and apoptotic signaling pathways in PEITC-mediated responses in human HT-29 colon adenocarcinoma cells. Carcinogenesis 24 (2003) 1361-1367
19. Kim B.R., Hu R., Keum Y.S., Hebbar V., and Shen G. Effects of glutathione on antioxidant response element-mediated gene expression and apoptosis elicited by sulforaphane. Cancer Res. 63 (2003) 7520-7525
20. Huang C., Ma W.Y., Li J., Hecht S.S., and Dong Z. Essential role of p53 in phenethyl isothiocyanate-induced apoptosis. Cancer Res. 58 (1998) 4102-4106
21. Gamet-Payrastre L., Li P., Lumeau S., Cassar G., Dupont M.A., Chevolleau S., et al. Sulforaphane, a naturally occurring isothiocyanate, induces cell cycle arrest and apoptosis in HT29 human colon cancer cells. Cancer Res. 60 (2000) 1426-1433
22. Chiao J.W., Chung F., Krzeminski J., Amin S., Arshad R., Ahmed T., et al. Modulation of growth of human prostate cancer cells by the N-acetylcysteine conjugate of phenethyl isothiocyanate. Int. J. Oncol. 16 (2000) 1215-1219
23. Fahey J.W., Zhang Y., and Talalay P. Broccoli sprouts: an exceptionally rich source of inducers of enzymes that protect against chemical carcinogens. Proc. Natl Acad. Sci. USA 94 (1997) 10367-10372
24. Prochaska H.J., Santamaria A.B., and Talalay P. Rapid detection of inducers of enzymes that protect against carcinogens. Proc. Natl Acad. Sci. USA 89 (1992) 2394-2398
25. Zhang Y., Talalay P., Cho C.G., and Posner G.H. A major inducer of anticarcinogenic protective enzymes from broccoli: isolation and elucidation of structure. Proc. Natl Acad. Sci. USA 89 (1992) 2399-2403
26. McMahon M., Itoh K., Yamamoto M., Chanas S.A., Henderson C.J., McLellan L.I., et al. The Cap'n'Collar basic leucine zipper transcription factor Nrf2 (NF-E2 p45-related factor 2) controls both constitutive and inducible expression of intestinal detoxification and glutathione biosynthetic enzymes. Cancer Res. 61 (2001) 3299-3307
27. Hayes J.D., and McMahon M. Molecular basis for the contribution of the antioxidant responsive element to cancer chemoprevention. Cancer Lett. 174 (2001) 103-113
28. Zhang Y., Kensler T.W., Cho C.G., Posner G.H., and Talalay P. Anticarcinogenic activities of sulforaphane and structurally related synthetic norbornyl isothiocyanates. Proc. Natl Acad. Sci. USA 91 (1994) 3147-3150
29. Gerhauser C., You M., Liu J., Moriarty R.M., Hawthorne M., Mehta R.G., et al. Cancer chemopreventive potential of sulforamate, a novel analogue of sulforaphane that induces phase 2 drug-metabolizing enzymes. Cancer Res. 57 (1997) 272-278
30. Chung F.L., Conaway C.C., Rao C.V., and Reddy B.S. Chemoprevention of colonic aberrant crypt foci in fischer rats by sulforaphane and phenethyl isothiocyanate. Carcinogenesis 21 (2000) 2287-2291
31. Fahey J.W., Haristoy X., Dolan P.M., Kensler T.W., Scholtus I., Stephenson K.K., et al. Sulforaphane inhibits extracellular, intracellular, and antibiotic-resistant strains of helicobacter pylori and prevents benzo[a]pyrene-induced stomach tumors. Proc. Natl Acad. Sci. USA 99 (2002) 7610-7615
32. Kwak M.K., Itoh K., Yamamoto M., Sutter T.R., and Kensler T.W. Role of transcription factor Nrf2 in the induction of hepatic phase 2 and antioxidative enzymes in vivo by the cancer chemoprotective agent, 3H-1, 2-dimethiole-3-thione. Mol. Med. 7 (2001) 135-145
33. Aoki Y., Sato H., Nishimura N., Takahashi S., Itoh K., and Yamamoto M. Accelerated DNA adduct formation in the lung of the Nrf2 knockout mouse exposed to diesel exhaust. Toxicol. Appl. Pharmacol. 173 (2001) 154-160
34. Chanas S.A., Jiang Q., McMahon M., McWalter G.K., McLellan L.I., Elcombe C.R., et al. Loss of the Nrf2 transcription factor causes a marked reduction in constitutive and inducible expression of the glutathione S-transferase Gsta1, Gsta2, Gstm1, Gstm2, Gstm3 and Gstm4 genes in the livers of male and female mice. Biochem. J. 365 (2002) 405-416
35. Hayes J.D., Chanas S.A., Henderson C.J., McMahon M., Sun C., Moffat G.J., et al. The Nrf2 transcription factor contributes both to the basal expression of glutathione S-transferases in mouse liver and to their induction by the chemopreventive synthetic antioxidants, butylated hydroxyanisole and ethoxyquin. Biochem. Soc. Trans. 28 (2000) 33-41
36. Ishii T., Itoh K., Takahashi S., Sato H., Yanagawa T., Katoh Y., et al. Transcription factor Nrf2 coordinately regulates a group of oxidative stress-inducible genes in macrophages. J. Biol. Chem. 275 (2000) 16023-16029
37. Nguyen T., Huang H.C., and Pickett C.B. Transcriptional regulation of the antioxidant response element. Activation by Nrf2 and repression by MafK. J. Biol. Chem. 275 (2000) 15466-15473
38. Wild A.C., Moinova H.R., and Mulcahy R.T. Regulation of gamma-glutamylcysteine synthetase subunit gene expression by the transcription factor Nrf2. J. Biol. Chem. 274 (1999) 33627-33636
39. Alam J., Stewart D., Touchard C., Boinapally S., Choi A.M., and Cook J.L. Nrf2, a Cap'n'Collar transcription factor, regulates induction of the heme oxygenase-1 gene. J. Biol. Chem. 274 (1999) 26071-26078
40. Lee J.M., Moehlenkamp J.D., Hanson J.M., and Johnson J.A. Nrf2-dependent activation of the antioxidant responsive element by tert-butylhydroquinone is independent of oxidative stress in IMR-32 human neuroblastoma cells. Biochem. Biophys. Res. Commun. 280 (2001) 286-292
41. Lee J.M., Hanson J.M., Chu W.A., and Johnson J.A. Phosphatidylinositol 3-kinase, not extracellular signal-regulated kinase, regulates activation of the antioxidant-responsive element in IMR-32 human neuroblastoma cells. J. Biol. Chem. 276 (2001) 20011-20016
42. Kim Y.C., Masutani H., Yamaguchi Y., Itoh K., Yamamoto M., and Yodoi J. Hemin-induced activation of the thioredoxin gene by Nrf2. A differential regulation of the antioxidant responsive element by a switch of its binding factors. J. Biol. Chem. 276 (2001) 18399-18406
43. Chan K., Han X.D., and Kan Y.W. An important function of Nrf2 in combating oxidative stress: detoxification of acetaminophen. Proc. Natl Acad. Sci. USA 98 (2001) 4611-4616
44. Chan K., and Kan Y.W. Nrf2 is essential for protection against acute pulmonary injury in mice. Proc. Natl Acad. Sci. USA 96 (1999) 12731-12736
45. Braun S., Hanselmann C., Gassmann M.G., auf dem Keller U., Born-Berclaz C., Chan K., et al. Nrf2 transcription factor, a novel target of keratinocyte growth factor action which regulates gene expression and inflammation in the healing skin wound. Mol. Cell. Biol. 22 (2002) 5492-5505
46. Itoh K., Chiba T., Takahashi S., Ishii T., Igarashi K., Katoh Y., et al. An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem. Biophys. Res. Commun. 236 (1997) 313-322
47. Duffy S., So A., and Murphy T.H. Activation of endogenous antioxidant defenses in neuronal cells prevents free radical-mediated damage. J. Neurochem. 71 (1998) 69-77
48. Hu R., Hebbar V., Kim B.R., Chen C., Winnik B., Buckley B., et al. In vivo pharmacokinetics and regulation of gene expression profiles by isothiocyanate sulforaphane in the rat. J. Pharmacol. Exp. Ther. 310 (2004) 263-271
49. Paolini M., Perocco P., Canistro D., Valgimigli L., Pedulli G.F., Iori R., et al. Induction of cytochrome P450, generation of oxidative stress and in vitro cell-transforming and DNA-damaging activities by glucoraphanin, the bioprecursor of the chemopreventive agent sulforaphane found in broccoli. Carcinogenesis 25 (2004) 61-67
50. Yu R., Lei W., Mandlekar S., Weber M.J., Der C.J., Wu J., et al. Role of a mitogen-activated protein kinase pathway in the induction of phase II detoxifying enzymes by chemicals. J. Biol. Chem. 274 (1999) 27545-27552
51. Maheo K., Morel F., Langouet S., Kramer H., Le Ferrec E., Ketterer B., et al. Inhibition of cytochromes P-450 and induction of glutathione S-transferases by sulforaphane in primary human and rat hepatocytes. Cancer Res. 57 (1997) 3649-3652
52. Munday R., and Munday C.M. Induction of phase II detoxification enzymes in rats by plant-derived isothiocyanates: comparison of allyl isothiocyanate with sulforaphane and related compounds. J. Agric. Food Chem. 52 (2004) 1867-1871
53. Knights K.M., and Drogemuller C.J. Xenobiotic-CoA ligases: kinetic and molecular characterization. Curr. Drug Metab. 1 (2000) 49-66
54. Lee J.M., Calkins M.J., Chan K., Kan Y.W., and Johnson J.A. Identification of the NF-E2-related factor-2-dependent genes conferring protection against oxidative stress in primary cortical astrocytes using oligonucleotide microarray analysis. J. Biol. Chem. 278 (2003) 12029-12038
55. Forrest G.L., and Gonzalez B. Carbonyl reductase. Chem. Biol. Interact. 129 (2000) 21-40
56. Oppermann U.C., and Maser E. Molecular and structural aspects of xenobiotic carbonyl metabolizing enzymes. Role of reductases and dehydrogenases in xenobiotic phase I reactions. Toxicology 144 (2000) 71-81
57. Yoshihara S., and Ohta S. Involvement of hepatic aldehyde oxidase in conversion of 1-methyl-4-phenyl-2,3-dihydropyridinium (MPDP+) to 1-methyl-4-phenyl-5,6-dihydro-2-pyridone. Arch. Biochem. Biophys. 360 (1998) 93-98
58. Tanaka T., Nakamura H., Nishiyama A., Hosoi F., Masutani H., Wada H., et al. Redox regulation by thioredoxin superfamily; protection against oxidative stress and aging. Free Radic. Res. 33 (2000) 851-855
59. Takahashi S., Sakai J., Fujino T., Hattori H., Zenimaru Y., Suzuki J., et al. The very low-density lipoprotein (VLDL) receptor: characterization and functions as a peripheral lipoprotein receptor. J. Atheroscler. Thromb. 11 (2004) 200-208
60. Houry W.A. Chaperone-assisted protein folding in the cell cytoplasm. Curr. Protein Pept. Sci. 2 (2001) 227-244
61. Gabai V.L., Meriin A.B., Yaglom J.A., Volloch V.Z., and Sherman M.Y. Role of Hsp70 in regulation of stress-kinase JNK: implications in apoptosis and aging. Fed. Eur. Biochem. Soc. Lett. 438 (1998) 1-4
62. Gabai V.L., Meriin A.B., Mosser D.D., Caron A.W., Rits S., Shifrin V.I., et al. Hsp70 prevents activation of stress kinases. A novel pathway of cellular thermotolerance. J. Biol. Chem. 272 (1997) 18033-18037
63. Samali A., and Orrenius S. Heat shock proteins: regulators of stress response and apoptosis. Cell Stress Chaperones 3 (1998) 228-236
64. Johnson J.L., and Craig E.A. Protein folding in vivo: unraveling complex pathways. Cell 90 (1997) 201-204
65. Watt R., and Piper P.W. UBI4, the polyubiquitin gene of saccharomyces cerevisiae, is a heat shock gene that is also subject to catabolite derepression control. Mol. Gen. Genet. 253 (1997) 439-447
66. Hershko A., and Ciechanover A. The ubiquitin system. Annu. Rev. Biochem. 67 (1998) 425-479
67. Sekhar K.R., Yan X.X., and Freeman M.L. Nrf2 degradation by the ubiquitin proteasome pathway is inhibited by KIAA0132, the human homolog to INrf2. Oncogene 21 (2002) 6829-6834
68. Kwak M.K., Wakabayashi N., Itoh K., Motohashi H., Yamamoto M., and Kensler T.W. Modulation of gene expression by cancer chemopreventive dithiolethiones through the Keap1-Nrf2 pathway. Identification of novel gene clusters for cell survival. J. Biol. Chem. 278 (2003) 8135-8145
69. Jakubikova J., Sedlak J., Mithen R., and Bao Y. Role of PI3K/Akt and MEK/ERK signaling pathways in sulforaphane- and erucin-induced phase II enzymes and MRP2 transcription, G(2)/M arrest and cell death in Caco-2 cells. Biochem. Pharmacol. 69 (2005) 1543-1552
70. Maher J.M., Cheng X., Slitt A.L., Dieter M.Z., and Klaassen C.D. Induction of the Mrp family of transporters by chemical activators of receptor-mediated pathways in mouse liver. Drug Metab. Dispos. (2005)
71. Xu C., Li C.Y., and Kong A.N. Induction of phase I, II and III drug metabolism/transport by xenobiotics. Arch. Pharm. Res. 28 (2005) 249-268
72. Thimmulappa R.K., Mai K.H., Srisuma S., Kensler T.W., Yamamoto M., and Biswal S. Identification of Nrf2-regulated genes induced by the chemopreventive agent sulforaphane by oligonucleotide microarray. Cancer Res. 62 (2002) 5196-5203
73. Dhakshinamoorthy S., and Jaiswal A.K. Small maf (MafG and MafK) proteins negatively regulate antioxidant response element-mediated expression and antioxidant induction of the NAD(P)H:quinone oxidoreductase1 gene. J. Biol. Chem. 275 (2000) 40134-40141
74. Dhakshinamoorthy S., and Jaiswal A.K. c-Maf negatively regulates ARE-mediated detoxifying enzyme genes expression and anti-oxidant induction. Oncogene 21 (2002) 5301-5312
75. He C.H., Gong P., Hu B., Stewart D., Choi M.E., Choi A.M., et al. Identification of activating transcription factor 4 (ATF4) as an Nrf2-interacting protein. Implication for heme oxygenase-1 gene regulation. J. Biol. Chem. 276 (2001) 20858-20865
76. Dhakshinamoorthy S., and Jaiswal A.K. Functional characterization and role of INrf2 in antioxidant response element-mediated expression and antioxidant induction of NAD(P)H:quinone oxidoreductase1 gene. Oncogene 20 (2001) 3906-3917
77. Kwak M.K., Itoh K., Yamamoto M., and Kensler T.W. Enhanced expression of the transcription factor Nrf2 by cancer chemopreventive agents: role of antioxidant response element-like sequences in the nrf2 promoter. Mol. Cell. Biol. 22 (2002) 2883-2892
78. Kensler T.W., Groopman J.D., Sutter T.R., Curphey T.J., and Roebuck B.D. Development of cancer chemopreventive agents: oltipraz as a paradigm. Chem. Res. Toxicol. 12 (1999) 113-126